Plasma FSTL-1 as a noninvasive diagnostic biomarker for patients with advanced liver fibrosis
Plasma FSTL-1 has high diagnostic accuracy and could potentially reduce the need for liver biopsy in identifying patients with advanced liver fibrosis.
Authors
- Xiaolong Qi (ORCID: https://orcid.org/0000-0002-3559-5855)
- Feng Cheng
- Xiaoguo Li (ORCID: https://orcid.org/0000-0002-5592-0176)
- Jianhua Rao (ORCID: https://orcid.org/0000-0003-1222-7707)
- Xuan Xiao
- Long Zhang (ORCID: https://orcid.org/0000-0001-8139-0474)
- Mingmin Sun
- Wenzhu Li (ORCID: https://orcid.org/0000-0003-1966-1151)
- Junda Li (ORCID: https://orcid.org/0009-0008-3241-8483)
- Song Yung Sun (ORCID: https://orcid.org/0000-0003-4524-188X)
- Wei Xu (ORCID: https://orcid.org/0000-0002-0728-7644)
- Yongquan Chi (ORCID: https://orcid.org/0009-0000-3509-0315)
Institutions
- Chinese Academy of Medical Sciences & Peking Union Medical College (CN)
- Zhongda Hospital Southeast University (CN)
- State Key Laboratory of Digital Medical Engineering (CN)
- Southeast University (CN)
- Nanjing Medical University (CN)
Publication Details
- Journal
- Hepatology
- Published
- 2024-11-21
- DOI
- https://doi.org/10.1097/hep.0000000000001167
- Citations
- 13
- Primary Topic
- Liver Disease Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 5.03